Sponsored Content
Advertisement
Articles by Sponsored Content
Vincent Herrin, MD - University of Mississippi Medical Center Jackson, Mississippi
Advertisement
Latest Updated Articles
- POLIVY + BR: A Therapeutic Option Granted Accelerated Approval for R/R 3/L+DLBCL, NOS
Published: February 2nd 2020 | Updated:
- The Proposed Mechanism of Action of POLIVY for R/R DLBCL, NOS
Published: February 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Priority Review to Dato-DXd First-Line Metastatic TNBC
2
FDA Accepts NDA of Zanzalintinib Combo for Pretreated Metastatic CRC
3
Dr Shubham Pant Highlights Progress and Promise in Pancreatic Cancer Treatment
4
Gemogenovatucel-T Triples Overall Survival in High-Risk HRP Ovarian Cancer
5